HZ5-58359-92075
2 vaccinations
6 coded responses
25 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 223 / VA
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-23
Dose 1 — Pfizer-BioNTech
- 2021-03-23
- 2021-03-24
-
2021-03-25
Survey response — days 1–6 daily, dose 1MedDRA: Decreased appetite — Feeling: Good · Site: PainFree text: Lack of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-06
-
2021-04-13
Dose 2 — Pfizer-BioNTech
- 2021-04-13
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: FairFree text: Asthma issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-17
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: Fair · HeadacheFree text: Asthma issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Headache, Fatigue or tirednessFree text: Asthma issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
-
2021-07-13
Survey response — 3 months, dose 2MedDRA: Abdominal pain, Decreased appetite — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Loss of appetite, extreme abdominal painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-13
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-22
-
2021-07-22
Call successfulDoes not wish to fill out VAERS report
- 2021-10-12
-
2022-04-13
Survey response — 12 months, dose 2MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy · Healthcare visit (other): Ob gynMedDRA releases: 2024-11 · check-in free text available
-
2022-04-13
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Lack of appetite
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Asthma issues
Systemic reaction (other): Asthma issues
Systemic reaction (other): Asthma issues
Release 9 — 3 months, dose 2
Symptoms: Loss of appetite, extreme abdominal pain
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Asthma | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release